Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer

NCT02733250 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators